SYT7通过相互作用和调节KNTC1来调节慢性淋巴细胞白血病的进展
Wenjie Zhang1, Jinlan Long1, Peixia Tang1
1Fujian Provincial Key Laboratory on Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, 29 Xinquan Rd, Fuzhou, 350001, China.
赛纳普托塔明7 (SYT7) 通过抑制KNTC1无处置,促进慢性淋巴细胞白血病 (CLL) 的进展. 针对SYT7可能为CLL患者提供新的治疗策略.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 慢性淋巴细胞白血病 (CLL) 是一种常见的白血病,病程可变,其致病性尚未完全理解.
- 综合色素7 (SYT7) 涉及固体瘤,但其在CLL中的作用尚不清楚.
研究的目的:
- 在慢性淋巴细胞白血病 (CLL) 中研究Synaptotagmin 7 (SYT7) 的功能和分子机制.
主要方法:
- 通过免疫组织化学和qPCR分析SYT7表达.
- 在体外和体内实验中评估了SYT7在CLL发展中的作用.
- 基因芯片分析和共免疫沉阐明了分子机制.
主要成果:
- SYT7敲击抑制了CLL细胞的增殖,迁移和抗亡,并减少了异种移植瘤的生长.
- 在体外,SYT7过度表达促进了CLL的发展.
- SYT7通过抑制SYVN1介导的KNTC1无处置而起作用,而KNTC1的淘汰扭转了SYT7的影响.
结论:
- SYT7通过SYVN1-介导的KNTC1无处不在途径驱动CLL的进展.
- SYT7代表了对CLL治疗的潜在分子标.
更多相关视频
09:52A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
09:09Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation
Published on: November 10, 2017
相关概念视频
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Regulation of Nuclear Protein Sorting
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Inhibition of Cdk Activity
